These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35908353)

  • 1. Magnesium isoglycyrrhizinate ameliorates lipopolysaccharide-induced liver injury by upregulating autophagy and inhibiting inflammation via IL-22 expression.
    Zhou X; Li X; Yi K; Liang C; Geng S; Zhu J; Xie C; Zhong C
    Bioorg Chem; 2022 Nov; 128():106034. PubMed ID: 35908353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnesium isoglycyrrhizinate suppresses LPS-induced inflammation and oxidative stress through inhibiting NF-κB and MAPK pathways in RAW264.7 cells.
    Xie C; Li X; Zhu J; Wu J; Geng S; Zhong C
    Bioorg Med Chem; 2019 Feb; 27(3):516-524. PubMed ID: 30617018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnesium Isoglycyrrhizinate Alleviates Arsenic Trioxide-Induced Cardiotoxicity: Contribution of Nrf2 and TLR4/NF-κB Signaling Pathway.
    Zheng B; Yang Y; Li J; Li J; Zuo S; Chu X; Xu S; Ma D; Chu L
    Drug Des Devel Ther; 2021; 15():543-556. PubMed ID: 33603344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnesium isoglycyrrhizinate attenuates D-galactosamine/lipopolysaccharides induced acute liver injury of rat via regulation of the p38-MAPK and NF-κB signaling pathways.
    Wang W; Li X; Xu J
    Immunopharmacol Immunotoxicol; 2018 Jun; 40(3):262-267. PubMed ID: 29486613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibition of Hippo/Yap signaling pathway is required for magnesium isoglycyrrhizinate to ameliorate hepatic stellate cell inflammation and activation.
    Li L; Zhou J; Li Q; Xu J; Qi J; Bian H
    Biomed Pharmacother; 2018 Oct; 106():83-91. PubMed ID: 29957470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnesium isoglycyrrhizinate ameliorates concanavalin A-induced liver injury via the p38 and JNK MAPK pathway.
    Gao Y; Tian Y; Zhang X; Zhang X; Duan Z; Ren F; Chen Y
    Immunopharmacol Immunotoxicol; 2020 Oct; 42(5):445-455. PubMed ID: 32787473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of the hepatoprotective effect and mechanism of magnesium isoglycyrrhizinate in mice with arsenic trioxide‑induced acute liver injury.
    Liu M; Zheng B; Liu P; Zhang J; Chu X; Dong C; Shi J; Liang Y; Chu L; Liu Y; Han X
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnesium isoglycyrrhizinate alleviates liver injury in obese rats with acute necrotizing pancreatitis.
    Mei F; Yu J; Li M; Xiang M; Hong Y; Zhou Y; You Y; Xia H; Jin H; Wang W
    Pathol Res Pract; 2019 Jan; 215(1):106-114. PubMed ID: 30396756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnesium Isoglycyrrhizinate Ameliorates Concanavalin A-Induced Liver Injury by Inhibiting Autophagy.
    Fan Z; Li Y; Chen S; Xu L; Tian Y; Cao Y; Pan Z; Zhang X; Chen Y; Ren F
    Front Pharmacol; 2021; 12():794319. PubMed ID: 35058778
    [No Abstract]   [Full Text] [Related]  

  • 10. Magnesium isoglycyrrhizinate prevents cadmium-induced activation of JNK and apoptotic hepatocyte death by reversing ROS-inactivated PP2A.
    Chen X; Wang X; Yang L; Xu H; Wu Y; Wu J; Chen L; Xu C
    J Pharm Pharmacol; 2021 Dec; 73(12):1663-1674. PubMed ID: 34468764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnesium isoglycyrrhizinate prevents the nonalcoholic hepatic steatosis via regulating energy homeostasis.
    Jiang W; Xu S; Guo H; Lu L; Liu J; Wang G; Hao K
    J Cell Mol Med; 2020 Jul; 24(13):7201-7213. PubMed ID: 32410294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects against and potential mechanisms underlying the effect of magnesium isoglycyrrhizinate in hypoxia-reoxygenation injury in rat liver cells.
    Zheng J; Wu G; Hu GX; Peng YZ; Xiong XJ
    Genet Mol Res; 2015 Dec; 14(4):15453-61. PubMed ID: 26634511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of Ethanol-Induced Hepatitis by Magnesium Isoglycyrrhizinate through Inhibition of Neutrophil Cell Infiltration and Oxidative Damage.
    Wang Y; Zhang Z; Wang X; Qi D; Qu A; Wang G
    Mediators Inflamm; 2017; 2017():3526903. PubMed ID: 28951632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnesium Isoglycyrrhizinate Attenuates Anti-Tuberculosis Drug-Induced Liver Injury by Enhancing Intestinal Barrier Function and Inhibiting the LPS/TLRs/NF-κB Signaling Pathway in Mice.
    Gong JY; Ren H; Chen HQ; Xing K; Xiao CL; Luo JQ
    Pharmaceuticals (Basel); 2022 Sep; 15(9):. PubMed ID: 36145350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hepatoprotective effects of XCHD and MgIG against methotrexate-induced liver injury and inflammation in rats through suppressing the activation of AIM2 inflammasomes.
    Chen C; Liu YH; Cheng SB; Wu SL; Zhai XJ
    Pathol Res Pract; 2020 Apr; 216(4):152875. PubMed ID: 32113793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of hedgehog pathway is required for the protective effects of magnesium isoglycyrrhizinate against ethanol-induced hepatocyte steatosis and apoptosis.
    Lu C; Xu W; Shao J; Zhang F; Chen A; Zheng S
    IUBMB Life; 2017 Jul; 69(7):540-552. PubMed ID: 28500689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnesium isoglycyrrhizinate promotes the activated hepatic stellate cells apoptosis via endoplasmic reticulum stress and ameliorates fibrogenesis in vitro and in vivo.
    Bian M; Chen X; Zhang C; Jin H; Wang F; Shao J; Chen A; Zhang F; Zheng S
    Biofactors; 2017 Nov; 43(6):836-846. PubMed ID: 29048780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnesium isoglycyrrhizinate has hepatoprotective effects in an oxaliplatin‑induced model of liver injury.
    Zou X; Wang Y; Peng C; Wang B; Niu Z; Li Z; Niu J
    Int J Mol Med; 2018 Oct; 42(4):2020-2030. PubMed ID: 30066834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of myocardial hypertrophy by magnesium isoglycyrrhizinate through the TLR4/NF-κB signaling pathway in mice.
    Ma D; Zhang J; Zhang Y; Zhang X; Han X; Song T; Zhang Y; Chu L
    Int Immunopharmacol; 2018 Feb; 55():237-244. PubMed ID: 29274625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnesium isoglycyrrhizinate blocks fructose-induced hepatic NF-κB/NLRP3 inflammasome activation and lipid metabolism disorder.
    Zhao XJ; Yang YZ; Zheng YJ; Wang SC; Gu HM; Pan Y; Wang SJ; Xu HJ; Kong LD
    Eur J Pharmacol; 2017 Aug; 809():141-150. PubMed ID: 28526339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.